AXGN Axogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AXGN

Price (delayed)

$6.63

Market cap

$286.46M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.51

Enterprise value

$321.71M

Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore ...

Highlights
The company's EPS rose by 26% YoY and by 9% QoQ
Axogen's net income has increased by 25% YoY and by 7% QoQ
Axogen's quick ratio has decreased by 37% YoY and by 12% from the previous quarter
The equity has decreased by 5% YoY and by 2.2% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.axogeninc.com
Peers: MDT TMO BSX

Key stats

What are the main financial stats of AXGN
Market
Shares outstanding
43.21M
Market cap
$286.46M
Enterprise value
$321.71M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.98
Price to sales (P/S)
1.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.02
Earnings
Revenue
$159.01M
EBIT
-$18.88M
EBITDA
-$13.33M
Free cash flow
-$19.59M
Per share
EPS
-$0.51
Free cash flow per share
-$0.46
Book value per share
$2.22
Revenue per share
$3.71
TBVPS
$4.48
Balance sheet
Total assets
$196.83M
Total liabilities
$101.16M
Debt
$72.28M
Equity
$95.67M
Working capital
$57.57M
Liquidity
Debt to equity
0.76
Current ratio
2.89
Quick ratio
2.04
Net debt/EBITDA
-2.65
Margins
EBITDA margin
-8.4%
Gross margin
80.4%
Net margin
-13.7%
Operating margin
-13.5%
Efficiency
Return on assets
-11.2%
Return on equity
-22.4%
Return on invested capital
-9.2%
Return on capital employed
-11.3%
Return on sales
-11.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AXGN stock price

How has the Axogen stock price performed over time
Intraday
1.69%
1 week
2%
1 month
-12.19%
1 year
-27.78%
YTD
-2.93%
QTD
-17.84%

Financial performance

How have Axogen's revenue and profit performed over time
Revenue
$159.01M
Gross profit
$127.87M
Operating income
-$21.46M
Net income
-$21.72M
Gross margin
80.4%
Net margin
-13.7%
AXGN's operating margin is up by 37% YoY and by 14% QoQ
The company's net margin rose by 34% YoY and by 10% QoQ
Axogen's operating income has increased by 28% YoY and by 10% from the previous quarter
Axogen's net income has increased by 25% YoY and by 7% QoQ

Growth

What is Axogen's growth rate over time

Valuation

What is Axogen stock price valuation
P/E
N/A
P/B
2.98
P/S
1.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.02
The company's EPS rose by 26% YoY and by 9% QoQ
AXGN's P/B is 33% below its 5-year quarterly average of 4.4 and 14% below its last 4 quarters average of 3.4
The equity has decreased by 5% YoY and by 2.2% QoQ
AXGN's P/S is 58% below its 5-year quarterly average of 4.2 and 20% below its last 4 quarters average of 2.2
The revenue has grown by 15% YoY and by 4.4% from the previous quarter

Efficiency

How efficient is Axogen business performance
The company's return on sales rose by 42% YoY and by 18% QoQ
Axogen's return on invested capital has increased by 28% YoY and by 13% QoQ
The ROA has increased by 24% YoY and by 7% from the previous quarter
Axogen's ROE has increased by 21% YoY and by 5% from the previous quarter

Dividends

What is AXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AXGN.

Financial health

How did Axogen financials performed over time
The total assets is 95% higher than the total liabilities
Axogen's quick ratio has decreased by 37% YoY and by 12% from the previous quarter
AXGN's current ratio is down by 30% year-on-year and by 12% since the previous quarter
The company's debt is 24% lower than its equity
The debt to equity has grown by 7% YoY and by 4.1% from the previous quarter
The equity has decreased by 5% YoY and by 2.2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.